News und Analysen
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website
NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities
Transgene Announces Financial Calendar for 2022
Regulatory News:
TRANSGENE (Paris: TNG) today announced its financial reporting dates for 2022:
March 16, 2022: 2021 Fiscal Year Results
May 10, 2022: First Quarter 2022 Financial Results
NANOBIOTIX Announces First Patient Enrolled in NANORAY-312 Global Phase III Registrational Study of NBTXR3 in Head and Neck Cancer
Regulatory News:
NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX – the “Company”), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for
Nanobiotix Announces Participation at Three Virtual Investor Conferences in January 2022
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities
Poxel Announces Financial Calendar for 2022
POXEL SA (Euronext – POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic diseases with metabolic pathophysiology, including non-alcoholic
Transgene Announces Investor Meetings for January 2022
Regulatory News:
TRANSGENE (Paris:TNG) today announces that Management will participate in the upcoming investor events set out below.
Transgene will meet institutional investors at the 11th
Verimatrix: Neuer Finanzkalender
Pflichtmitteilung:
Verimatrix (Paris:VMX) (Euronext Paris: VMX) hat heute den Kalender für die Veröffentlichung der Jahresergebnisse 2021 und die Präsentation des neuen Strategieplans („New
Verimatrix: New Financial Calendar
Regulatory News:
Verimatrix (Paris:VMX) (Euronext Paris: VMX), today announced its calendar for the communication of the Annual Results of 2021 and the presentation of the New Strategic Plan:
-
Transgene announces License Option Exercise by AstraZeneca for an Oncolytic Virus Generated by Transgene’s Invir.IO™ Platform
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announces that AstraZeneca
Poxel Announces its Participation at Upcoming Investor and Scientific Conferences in January 2022
POXEL SA (Euronext – POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website
Gaussin, Gam Qatar and GWC Establish a Partnership to Trial Gaussin’s Zero-Emission Electric Tractors and Yard Automation Solutions
GAUSSIN (EURONEXT GROWTH ALGAU - FR0010342329), a pioneer of clean and smart freight transport, Gam Qatar and GWC (GWCS.QA), Qatar’s leading logistics and supply chain solutions provider, have
ARAMCO and GAUSSIN Sign a Partnership to Join Forces in the Hydrogen Vehicle Business
ARAMCO, one of the world’s leading integrated energy and chemicals companies, and GAUSSIN (ALGAU - FR0013495298), a pioneer in the clean and intelligent transport of goods and people, have started
Poxel Announces the Formation of its Scientific Advisory Board for Rare Metabolic Diseases
POXEL SA (Euronext – POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic diseases with metabolic pathophysiology, including non-alcoholic
Enseo beauftragt Verimatrix mit Schutz von Unterhaltungsinhalten, die über neue Set-Top-Boxen bereitgestellt werden
Regulatory News:
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von benutzerorientierten Sicherheitslösungen für die moderne vernetzte Welt, meldete heute, dass Enseo, ein führender
CORRECTING and REPLACING: Apave, ESI Group and Onet Technologies – A unique alliance for an outstanding EPR project at the Jaitapur site in India
Regulatory News:
This replaces the announcement made at 3:15 PM on December 1st due to the following corrections: Last quote was cancelled.
Apave, ESI Group and Onet Technologies – A unique
Enseo Selects Verimatrix To Protect Entertainment Content Provided Via New Set Top Boxes
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Plano, Texas-based Enseo, the premier
ESI Group stellt neues Führungsteam vor
Die ESI Group (ISIN Code: FR0004110310, Symbol: ESI) (Paris:ESI) gab heute bekannt, dass das Unternehmen die Bildung seines neuen Führungsteams durch erfahrene Experten der aktuellen Organisation
Verimatrix bringt mit Streamkeeper, die branchenweit erste schlagkräftige Cybersecurity-Lösung zur Verfolgung und Bekämpfung von Videopiraterie, auf den Markt
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute die Markteinführung seiner neuen Lösung
Is Lam Research the Semiconductor Stock You’ve Been Overlooking?
Lam Research (NASDAQ: LRCX) is a lesser-known company in the semiconductor industry compared to powerhouses like NVIDIA (NASDAQ: NVDA) and Taiwan Semiconductor (NYSE: TSM), but it is an important
Novo Nordisk's Shares Go on a Rollercoaster Ride After Earnings
Novo Nordisk (NYSE: NVO) is the world’s second-largest pharmaceutical company, with a market capitalization of $538 billion. The Danish firm’s shares have performed well so far in 2024
Semiconductor Stock Giant Beats on EPS, Faces Large Backlog
Cadence Design Systems (NASDAQ: CDNS) is a software company that makes programs essential to semiconductor design. The firm announced Q2 2024 earnings on July 22, 2024. Let’s break down
Academy Sports Stock is Selling at a Discount
Price action is starting to favor some retail stocks, but not all of them are created equal. Academy Sports and Outdoors Inc. (NASDAQ: ASO) is a discount you can score today. Even after rallying
Kaufman & Broad SA: AVAILABILITY OF THE PREPARATORY DOCUMENTS FOR THE COMBINED ORDINARY AND EXTRAORDINARY GENERAL MEETING OF 5 MAY 2022
